(Q30472797)

21 June 2017

1 reference

title

New approaches to influenza chemotherapy. Neuraminidase inhibitors (English)

1 reference

21 June 2017

0 references

1

Calfee DP

1 reference

21 June 2017

Hayden FG

2

1 reference

21 June 2017

publication date

1 October 1998

1 reference

21 June 2017

1 reference

21 June 2017

volume

56

1 reference

21 June 2017

issue

4

1 reference

21 June 2017

page(s)

537-553

1 reference

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

21 June 2017

cites work

1 reference

12 December 2020

Evaluation of a Neuraminidase-Specific Influenza A Virus Vaccine in Children: Antibody Responses and Effects on Two Successive Outbreaks of Natural Infection

1 reference

12 December 2020

Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine

1 reference

12 December 2020

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

12 December 2020

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor

1 reference

12 December 2020

Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors

1 reference

12 December 2020

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

1 reference

12 December 2020

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

1 reference

12 December 2020

Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid

1 reference

12 December 2020

Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza

1 reference

12 December 2020

Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104.

1 reference

12 December 2020

Protection against lethal influenza with neuraminidase

1 reference

12 December 2020

Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.

1 reference

12 December 2020

GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets

1 reference

12 December 2020

Mode of action of the anti-influenza virus activity of plant flavonoid, 5,7,4'-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis

1 reference

12 December 2020

A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies

1 reference

12 December 2020

Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en

1 reference

12 December 2020

Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase)

1 reference

12 December 2020

Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071.

1 reference

12 December 2020

4-Guanidino-Neu5Ac2en fails to protect chickens from infection with highly pathogenic avian influenza virus

1 reference

12 December 2020

Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase

1 reference

12 December 2020

Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en

1 reference

12 December 2020

Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection

1 reference

12 December 2020

Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction

1 reference

12 December 2020

Stimulation of tumor necrosis factor secretion by purified influenza virus neuraminidase

1 reference

12 December 2020

2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid (4-guanidino-Neu5Ac2en) is a slow-binding inhibitor of sialidase from both influenza A virus and influenza B virus

1 reference

12 December 2020

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

1 reference

12 December 2020

Chemoenzymatic synthesis of neuraminic acid analogs structurally varied at C-5 and C-9 as potential inhibitors of the sialidase from influenza virus

1 reference

12 December 2020

Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.

1 reference

12 December 2020

Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium

1 reference

12 December 2020

Effect of neuraminidase antibody on Hong Kong influenza

1 reference

12 December 2020

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

12 December 2020

Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en

1 reference

12 December 2020

Slow-binding inhibition of sialidase from influenza virus

1 reference

12 December 2020

In vivo anti-influenza virus activity of plant flavonoids possessing inhibitory activity for influenza virus sialidase

1 reference

12 December 2020

A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs

1 reference

12 December 2020

Influenza virus neuraminidase activates latent transforming growth factor beta.

1 reference

12 December 2020

Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid

1 reference

12 December 2020

Influenza virus neuraminidase: structure, antibodies, and inhibitors

1 reference

12 December 2020

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

12 December 2020

Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza

1 reference

12 December 2020

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid

1 reference

12 December 2020

10.2165/00003495-199856040-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

21 June 2017

1030069963

0 references

1 reference